Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | BI 907828 |
| Trade Name | |
| Synonyms | BI907828|BI-907828|Brigimadlin |
| Drug Descriptions |
BI 907828 is an MDM2 inhibitor that potentially inhibits tumor growth and improves anti-tumor immunity (PMID: 31201607; Cancer Res 2018;78(13 Suppl):Abstract nr 4866). |
| DrugClasses | MDM2 Inhibitor 23 |
| CAS Registry Number | 2095116-40-6 |
| NCIT ID | C156709 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| BI 907828 | BI 907828 | 3 | 5 |
| BI 907828 + Ezabenlimab | BI 907828 Ezabenlimab | 1 | 2 |
| BI 907828 + Ezabenlimab + Miptenalimab | BI 907828 Ezabenlimab Miptenalimab | 0 | 1 |
| BI 907828 + Rifampin | BI 907828 Rifampin | 0 | 0 |